Chongqing University of Arts and Science Ed new drugs won the first place in the team group of the final of the fourth China Innovation and entrepreneurship competition in biomedical industry

On October 9-12, LAN gang and Zhang Jin, vice presidents of the school, led the team, and Chongqing new medicine innovation team and Chongqing endangered aquatic resources protection team participated in the final of the fourth China Innovation and entrepreneurship competition in biomedical industry The "Chongqing new medicine innovation team" led by Professor Chen Zhongzhu of the "innovation target drug International Research Institute" of Chongqing University of Arts and Sciences has conquered the judges and audience with strong strength, won the first place in the team group of the national finals of biomedical industry in China Innovation and entrepreneurship competition, and won the best Popularity Award! It is reported that after more than three years of research, Chongqing new drug innovation team has developed a new drug that can effectively treat male sexual dysfunction At present, the team has a safe and independent intellectual property right of PDE5 kinase inhibition The project is undergoing clinical safety evaluation and will soon submit clinical application to FDA of the United States and CFDA of China It is expected to enter the market within 5 to 6 years (the new drug collection thinks it is impossible to achieve) China Innovation and entrepreneurship competition aims to implement the "innovation driven development strategy" of the CPC Central Committee and the State Council, respond to the call of "mass entrepreneurship and innovation", and promote the effective transformation of the latest research results in China According to relevant reports of Chongqing Evening News and Chongqing University of Arts and Sciences